Cannabis Law Report

MAY 19, 2022

.” Hartle, 54, is one of the very few Canadians to have received legal psychedelics psychotherapy for a mental health condition since Health Canada made it easier in January for health-care workers to access psilocybin — the hallucinogenic compound found in some mushrooms. ” Health Canada on Jan.

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

AUGUST 3, 2022

Eight Canadians have filed a Charter challenge against the Government of Canada and the Minister of Health regarding patient access to psilocybin and psilocybin therapy. It’s a similar argument to the landmark court case, R v Parker, which led to Canada’s first medical cannabis laws. The Patients / Plaintiffs.

Access 52

Access Patients Therapy Legalization 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

NORML

NOVEMBER 8, 2019

Yet, even in the majority of states where medical cannabis is legal, VA physicians are prohibited by federal law from filling out a state-legal medical marijuana recommendation form. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.

Access 200

Access Marijuana Treatment Legislation 200

Cannabis Law Report

JANUARY 6, 2022

CNSX : FTRP; OTCMKTS : FTRPF), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). Field Trip Health Ltd.

Access 52

Access Patients Therapy Conditions 52

Cannabis Law Report

MARCH 22, 2023

When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures equitable patient access, say experts.

Therapy 52

Therapy Treatment Conditions Access 52

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Canna Law Blog

NOVEMBER 10, 2020

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. It’s quite restrictive.

Therapy 78

Therapy Clinical Trials Decriminalization Patients 78

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

JUNE 7, 2021

Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Therapy 82

Therapy Treatment Conditions Clinical Trials 82

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

NORML

MAY 27, 2020

Senators on Wednesday passed legislation to significantly expand the pool of patients eligible to qualify for medical cannabis access. ” Under the current law , doctors may only recommend medical cannabis products to those patients with a limited number of select conditions, such as HIV and cancer. .”

Conditions 275

Conditions Legislation Therapy Patients 275

MMJ Recs

OCTOBER 9, 2023

As Texas residents seek alternative therapies for chronic pain and other debilitating conditions, it becomes crucial to navigate the world of MMJ pain management centers effectively. These centers differ in terms of services, expertise, and their approach to patient care. Top-Rated Medical Cannabis Clinics in Texas 1.

Chronic Pain 52

Chronic Pain Patients Treatment Conditions 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition.

Dispensary 52

Dispensary Patients Environment Conditions 52

MMJ Recs

JANUARY 20, 2024

With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! Verify your email address.

Law 52

Law Marijuana Patients Chronic Pain 52

The Cannigma

JUNE 2, 2023

The government remains steadfast in its commitment to maintaining strict drug laws to ensure public safety. The law unequivocally prohibits the possession, consumption, importation, and trafficking of cannabis. Law enforcement agencies in Singapore actively combat drug offenses. Is weed legal in Singapore?

Law 52

Law Research and Development Consumption Therapy 52

The Cannigma

JUNE 1, 2021

Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. Possessing cannabis is illegal in France, although in 2020, the country changed the law so that the punishment is now a €200 fine. The post Cannabis laws in France appeared first on The Cannigma.

Law 113

Law Epilepsy Programs Patients 113

United Patients Group

NOVEMBER 21, 2023

Traditional treatments with prescription medications can sometimes be insufficient or accompanied by undesirable side effects, leaving patients in search of alternative methods for pain relief. Harlequin is ideal for patients seeking clear-headed pain relief during daytime hours.

Chronic Pain 82

Chronic Pain Strains Patients Marijuana 82

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. About Curaleaf International.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

AUGUST 19, 2021

Cannim will sell its products in the EU medical markets through the Cantourage Fast Track Access Platform. The agreement allows medical cannabis flowers from Jamaica to be made available to German patients for the first time. Cantourage continues to provide innovative cultivars and a safe, diverse supply for patients”.

Access 98

Access Cultivation Patients Indica 98

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has the potential to reduce opioid dependence and addiction, leading to safer and healthier communities.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

MAY 9, 2024

As such, we provide you with a comprehensive guide for veterans using medical cannabis and the various aspects of it, including its usage, accessibility, legal considerations, healthcare options, and available resources. Navigating the complexities surrounding the Veterans Administration and medical cannabis can be daunting.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

DECEMBER 15, 2021

Another three patients who have petitioned the federal government to use psilocybin therapy as a treatment for their mental health conditions have received an exemption from the minister of health to legally undergo this therapy. . based non-profit TheraPsil, was one of the patients granted an exemption.

Patients 52

Patients Therapy Conditions Access 52

Veriheal

NOVEMBER 11, 2023

Simply put, in the eyes of federal law, cannabis is illegal. The Department of Veterans Affairs (VA) falls under federal government control which means it must obey all federal laws, including every cannabis law. According to Federal law, cannabis use is illegal. 5520), and the Veterans Equal Access Act (H.R.

Law 62

Law Chronic Pain Conditions Legislation 62

MMJ Recs

MARCH 20, 2024

Maryland medical cannabis dispensary services Maryland’s medical cannabis dispensaries offer comprehensive services tailored to meet the needs of registered patients. Trained dispensary staff assist patients in product selection, dosage recommendations, and consumption methods, ensuring personalized care and guidance.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” Psychedelic therapy is not a fringe phenomenon. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin.

Law 105

Law Therapy Clinical Trials Research and Development 105

MMJ Recs

JANUARY 24, 2024

As societal attitudes towards cannabis evolve and the medicinal benefits become increasingly recognized, Michigan’s program stands as a beacon of innovation, providing patients with a legal avenue to explore the therapeutic potential of marijuana.

Programs 52

Programs Marijuana Access Chronic Pain 52

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

Veriheal

JUNE 22, 2021

Over the next decade, the United States could stand to see an explosion in the research of cannabinoid therapies. As the medical understanding of cannabinoid therapies and their actions become more advanced, hopefully, the United States federal government will be able to keep up and adjust laws pertaining to cannabis accordingly.

DEA 59

DEA Access Therapy Cannabinoids 59

SpeedWeed

MARCH 11, 2021

“The case is about seeking to ensure that patients with serious, life-threatening illness are able to realize the promise of state and federal Right to Try laws and access psilocybin for therapeutic purposes.”. The state said the decision to use these drugs should be made by the patient and their doctor. .

DEA 52

DEA Patients Access Advocacy 52

Cannabis Law Report

JUNE 14, 2022

PAREA is a non-profit, multistakeholder and multidisciplinary partnership bringing together patient organizations, medical associations, scientific societies, psychedelic foundations, and the for-profit sector. The good news is that innovations that completely change the lives of patients continue to emerge.

Access 52

Access Therapy Clinical Trials Treatment 52

Cannabis Law Report

APRIL 2, 2022

Founded in 2019, Roots to Thrive is Canada’s first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week group therapy programs that include psilocybin-assisted and ketamine-assisted group therapy sessions.

Therapy 52

Therapy Research and Development Programs Legalization 52

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. Refractory pain refers to pain resistant to traditional treatment approaches such as medication, physical therapy, or surgery. However, these approaches are not always practical for everyone.

Treatment 109

Treatment Therapy Research and Development THC 109

Veriheal

APRIL 15, 2022

While most residents in these states only need to have a qualifying condition to get access, residents who belong to certain professions—such as healthcare workers—are prohibited from consumption regardless of medical need. Several council members are in support of allowing first responders access to the medical cannabis program in the state.

Access 52

Access THC Cannabis Legislation 52